Drug eruption is defined as an adverse cutaneous eruption secondary to drug intake. The most frequent variation is a morbilliform exanthema, although the clinical presentations may vary widely. The diagnosis is clinical, why thorough medical history and assessment are essential for the risk stratification of possible adverse cutaneous reaction. In Western hospitals, the prevalence is estimated to be 2-3% of the patients. Identification of the condition is therefore important for all healthcare professionals.
|Tidsskrift||Ugeskrift for Laeger|
|Status||Udgivet - 2018|